SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Hanouna-Boyard altercation: The LFI deputy filed a complaint for “insult” Nov 23, 2022
- PSG attacking tip awaits Cristiano Ronaldo Jul 25, 2021
- Covid: five tech devices to keep environments clean and disinfected Sep 21, 2021
- The fight that Canelo snatched from Jaime Munguía Jun 3, 2022
- Salobreña Sea Stain Reappears | Costa Tropical Gazette News Jul 27, 2021
- The specifications of the new phone that OnePlus is preparing are filtered | Technology May 31, 2021
- Una Vita, advances today 3 July: Genoveva’s plan against Agustina Jul 3, 2021